Previous close | 9.66 |
Open | 12.00 |
Bid | 7.50 |
Ask | 11.90 |
Strike | 60.00 |
Expiry date | 2024-10-18 |
Day's range | 9.66 - 13.20 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Intra-Cellular (ITCI) reports first-quarter 2024 results, wherein both earnings and revenues beat estimates, driven by strong Caplyta sales.
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.